Page last updated: 2024-08-16

technetium tc 99m sestamibi and Hypotension

technetium tc 99m sestamibi has been researched along with Hypotension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bax, JJ; Cornel, JH; Elhendy, A; Geleijnse, ML; Krenning, EP; Nierop, PR; Reijs, AE; Roelandt, JR; Valkema, R; van Domburg, RT1
Bielen, M; Karsera, D; Kulbertus, H; Mélon, P1

Other Studies

2 other study(ies) available for technetium tc 99m sestamibi and Hypotension

ArticleYear
Safety of dobutamine-atropine stress myocardial perfusion scintigraphy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:10

    Topics: Atropine; Coronary Disease; Dobutamine; Feasibility Studies; Female; Heart; Humans; Hypotension; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Risk Factors; Safety; Tachycardia; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon

1998
[Severe bradyarrhythmia during myocardial perfusion scintigraphy with injection of dipyridamole (Persantine)].
    Revue medicale de Liege, 1999, Volume: 54, Issue:2

    Topics: Aged; Arrhythmia, Sinus; Bradycardia; Dipyridamole; Electrocardiography; Female; Heart; Heart Block; Humans; Hypotension; Infusions, Intravenous; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Vasodilator Agents

1999